PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
11.73%
Revenue growth similar to MCHP's 10.82%. Walter Schloss would see if both companies share industry tailwinds.
14.88%
Gross profit growth similar to MCHP's 15.09%. Walter Schloss would assume both firms track common industry trends.
23.57%
EBIT growth below 50% of MCHP's 140.04%. Michael Burry would suspect deeper competitive or cost structure issues.
23.57%
Operating income growth under 50% of MCHP's 132.00%. Michael Burry would be concerned about deeper cost or sales issues.
38.27%
Net income growth under 50% of MCHP's 87.97%. Michael Burry would suspect the firm is falling well behind a key competitor.
60.00%
EPS growth at 75-90% of MCHP's 70.34%. Bill Ackman would push for improved profitability or share repurchases to catch up.
60.00%
Diluted EPS growth at 75-90% of MCHP's 70.34%. Bill Ackman would expect further improvements in net income or share count reduction.
-10.96%
Share reduction while MCHP is at 0.33%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-10.96%
Reduced diluted shares while MCHP is at 0.33%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
22.52%
Dividend growth above 1.5x MCHP's 10.17%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
121.15%
OCF growth above 1.5x MCHP's 33.85%. David Dodd would confirm a clear edge in underlying cash generation.
219.05%
FCF growth above 1.5x MCHP's 34.43%. David Dodd would verify if the firm’s strategic investments yield superior returns.
57.39%
10Y revenue/share CAGR 1.25-1.5x MCHP's 51.09%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
30.73%
Positive 5Y CAGR while MCHP is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
32.70%
Positive 3Y CAGR while MCHP is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
78.94%
Positive 3Y OCF/share CAGR while MCHP is negative. John Neff might see a big short-term edge in operational efficiency.
747.03%
Positive 10Y CAGR while MCHP is negative. John Neff might see a substantial advantage in bottom-line trajectory.
18.05%
Positive 5Y CAGR while MCHP is negative. John Neff might view this as a strong mid-term relative advantage.
921.88%
Positive short-term CAGR while MCHP is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-12.89%
Negative 3Y equity/share growth while MCHP is at 17.81%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
77.23%
Below 50% of MCHP's 180.63%. Michael Burry might see weaker long-term distribution growth, raising questions about the firm's capital allocation.
64.10%
Below 50% of MCHP's 175.02%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
0.36%
Below 50% of MCHP's 81.65%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
3.67%
AR growth is negative/stable vs. MCHP's 10.99%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
3.00%
We show growth while MCHP is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
2.34%
Positive asset growth while MCHP is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
18.75%
Positive BV/share change while MCHP is negative. John Neff sees a clear edge over a competitor losing equity.
-1.71%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
11.28%
SG&A growth well above MCHP's 4.80%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.